Outcomes for a Multi-institutional Cohort of Patients Treated With Intraoperative Radiation Therapy for Advanced or Recurrent Renal Cell Carcinoma
Jonathan J. Paly(Harvard University), J.A. Efstathiou(Massachusetts General Hospital), Peter J. Biggs(Massachusetts General Hospital), Felipe A. Calvo(Hospital General Universitario Gregorio Marañón), Falk Roeder(Heidelberg University), Christopher L. Hallemeier(Mayo Clinic in Arizona), Jared M. Whitson(University of California, San Francisco), Gert Fastner(University Clinic of Traumatology), A. Niemierko(Massachusetts General Hospital), Rafael Martínez‐Monge(Navarre Institute of Health Research)
International Journal of Radiation Oncology*Biology*Physics
October 25, 2012
Cited by 2
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Oesophageal cancer
|The Lancet|2024|265
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
|Practical Radiation Oncology|2021|261